National Taiwan University Hospital
Taipei, Taiwan, 100
NCT Number: NCT01934426
Objective: The study aim to establish high risk admission model and readmission model for elderly in Taiwan.
Method: Investigators compare the clinical, epidemiological, and socioeconomic characteristics of admitted patients during 1 August,2011 to 31 July,2012. All patients will follow up to end of study to identify 14 days readmission and 30 days readmission to geriatic ward.
Expected Outcomes: (1) To compare the prediction value of derivation cohort and validation cohort. (2) To identify high risk indicators of admission and readmission for elderly. (3) To determine the risk factors in admission elderly association with quality indicators.
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Taipei, Taiwan, 100
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1-year
Readmission in 14 days to geriatric ward is an important issue of elderly.
National Taiwan University Hospital
Other
Identification of Admission High Risk Elderly From Multiple Cohorts: a Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07532564
Anemia, Anemia, Hemolytic
Baltimore, Maryland, United States
View Trial DetailsNCT03694392
Acute Myocardial Infarction, Brain Diseases
Oakland, California, United States
View Trial DetailsNCT06770413
Aspiration, Brain Diseases
Seoul, South Korea
View Trial DetailsNCT00130221
Bacteremia, Bacterial Infections
Chicago, Illinois, United States
View Trial Details